Literature DB >> 15990987

Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.

A J Chamorro1, J L Casado, D Bellido, S Moreno.   

Abstract

Presented here is the first report of clinical reactivation of hepatitis B virus (HBV) in an HIV-infected patient who previously had anti-HBc as the only serological marker of past infection (anti-HBc alone). Reactivation occurred after lamivudine was removed from the patient's antiretroviral treatment regimen due to lack of virological response. HIV-infected patients frequently present anti-HBc alone, and in some cases this serological profile is associated with occult HBV infection. The current case demonstrates the importance of ruling out the possibility of occult infection in this patient group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990987     DOI: 10.1007/s10096-005-1355-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?

Authors:  Keisuke Hino; Ashraf A Basuni; Jacqueline Ireland; Antony Newell; Jeffrey Mphahlele; Erasmus J Smit; Siew Lin Ngui; Chong Gee Teo; William F Carman
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

2.  Reactivation of HBV replication in HIV-HBV infected patients.

Authors:  Firouzé Bani-Sadr; Anne Maillard; Diane Ponscarme; Catherine Scieux; Jean Michel Molina
Journal:  Am J Med       Date:  2003-06-15       Impact factor: 4.965

3.  Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine.

Authors:  M Bessesen; D Ives; L Condreay; S Lawrence; K E Sherman
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

4.  Hepatitis B virus infection in the acquired immunodeficiency syndrome.

Authors:  V K Rustgi; J H Hoofnagle; J L Gerin; E P Gelmann; C M Reichert; J N Cooper; A M Macher
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

5.  Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

Authors:  M Hofer; H I Joller-Jemelka; P J Grob; R Lüthy; M Opravil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

6.  Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.

Authors:  M Altfeld; J K Rockstroh; M Addo; B Kupfer; I Pult; H Will; U Spengler
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

7.  Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens.

Authors:  S C Hadler; B L Murphy; C A Schable; W L Heyward; D P Francis; M A Kane
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

8.  Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.

Authors:  R Monica Lascar; Richard J Gilson; A Ross Lopes; Antonio Bertoletti; Mala K Maini
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

9.  Viral hepatitis, type B. Studies on natural history and prevention re-examined.

Authors:  S Krugman; L R Overby; I K Mushahwar; C M Ling; G G Frösner; F Deinhardt
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

10.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

Authors:  Chloe L Thio; Eric C Seaberg; Richard Skolasky; John Phair; Barbara Visscher; Alvaro Muñoz; David L Thomas
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  17 in total

1.  Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption.

Authors:  S Bagaglio; L Porrino; A Lazzarin; G Morsica
Journal:  Infection       Date:  2010-06-09       Impact factor: 3.553

Review 2.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

3.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

5.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

6.  Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

Authors:  Woottichai Khamduang; Nicole Ngo-Giang-Huong; Catherine Gaudy-Graffin; Gonzague Jourdain; Weerapong Suwankornsakul; Tapnarong Jarupanich; Veeradate Chalermpolprapa; Sirisak Nanta; Noossara Puarattana-Aroonkorn; Sakchai Tonmat; Marc Lallemant; Alain Goudeau; Wasna Sirirungsi
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

Review 7.  Molecular characteristics and stages of chronic hepatitis B virus infection.

Authors:  Ying-Hui Shi; Chang-He Shi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

8.  Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

Authors:  Tara N Palmore; Neeral L Shah; Rohit Loomba; Brian B Borg; Uri Lopatin; Jordan J Feld; Farooq Khokhar; Glen Lutchman; David E Kleiner; Neal S Young; Richard Childs; A John Barrett; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-01       Impact factor: 11.382

Review 9.  Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Rev Med Virol       Date:  2018-05-15       Impact factor: 6.989

Review 10.  Persistent occult hepatitis B virus infection: experimental findings and clinical implications.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.